Project Number 5U01AG032973-02 Agency/Funding Organization NIA Funding Year 2012 View Full Project Details for NOVEL PDE5 INHIBITORS AS A THERAPEUTIC TOOL AGAINST ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator ARANCIO, OTTAVIO Principal Investigator First Name OTTAVIO Principal Investigator Last Name ARANCIO Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-08-266: ALZHEIMER'S DISEASE DRUG DEVELOPMENT PROGRAM (U01) FY Overall Cost $377,124 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA
